Innovating Works

NHSBT

Desconocido
SUPPORT-E: SUPporting high quality evaluation of COVID 19 convalescent Plasma thrOughoutT Europe NHS BLOOD AND TRANSPLANT participó en un H2020: Coronavirus disease 19 (COVID-19) is provoking the greatest global health crisis of this generation. With no vaccine or specific antiviral t...
2020-09-02 - 2025-12-31 | Financiado
AMELIE: Anchored Muscle cELls for IncontinencE NHS BLOOD AND TRANSPLANT participó en un H2020: H2020-SC1-BHC-2018-2020 Faecal incontinence (FI) is a common condition affecting ~67 million people in Europe, seriously impairing living and productivity of affect...
2020-05-06 - 2025-08-31 | Financiado
RenalToolBox: Developing novel tools and technologies to assess the safety and efficacy of cell based regenerative... NHS BLOOD AND TRANSPLANT participó en un H2020: H2020-MSCA-ITN-2018 The RenalToolBox ITN comprises a team of world-leading clinicians, scientists and industrialists from academia and private enterprise whose...
2018-09-13 - 2023-04-30 | Financiado
TETRA: Autologous Stem Cell Seeded Tissue Engineered Trachea NHS BLOOD AND TRANSPLANT participó en un H2020: H2020-PHC-2014-2015 CLINICAL PROBLEM AND UNMET NEED There are 11,827 patients with severe structural airway disease in Europe. Even with the current standard of...
2015-09-21 - 2019-12-31 | Financiado
NEPHSTROM: Novel Stromal Cell Therapy for Diabetic Kidney Disease NHS BLOOD AND TRANSPLANT participó en un H2020: H2020-PHC-2014-2015 Type 2 diabetes will affect >500 million adults by 2040 and its secondary complications will generate enormous socioeconomic costs - in part...
2015-04-08 - 2021-10-31 | Financiado
EUROSTAM: A Europe wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptab... NHS BLOOD AND TRANSPLANT participó en un FP7: The presence of donor specific HLA antibodies is a contra-indication for renal transplantation. Highly sensitized patients accumulate and of...
Financiado
MERLIN: MEsenchymal stem cells to Reduce Liver INflammation NHS BLOOD AND TRANSPLANT participó en un FP7: Prevalence of liver disease is c6% (29 million people) in the EU with mortality rates from chronic liver diseases estimated at 14.3 per 100....
Financiado
CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI NHS BLOOD AND TRANSPLANT participó en un FP7: Traumatic Brain Injury (TBI) is a major cause of death and disability, leading to great personal suffering to victim and relatives, as well...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.